CDK6 polyclonal antibody

• Background:

  The cyclin-dependent kinases form complexes with their cyclin partners and with CDK inhibitors. CDK6 and CDK4 associate with the D-type cyclins and target the retinoblastoma protein, allowing passage through the G1/S phase restriction point.

• Structure Composition:

  Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

• Product Name Alternative:

  CDK 6; Cell division protein kinase 6; Crk 2; Cyclin dependent kinase 6; p40; PLSTIRE; STQTL11

• Swiss Prot:

  Q00534

• Reactivity:

  Human

• Immunogen:

  A synthesized peptide derived from human CDK6

• Conjugation:

  Unconjugated

• Applications:

  WB, IHC-P, ICC/IF, FC

• Dilution:

  WB: 1/500-1/1000 IHC: 1/50-1/100 IF: 1/50-1/200 FC: 1/50-1/100

• Purity:

  Affinity Purified

• Modification:

  Unmodified

• Molecular Weight:

  Calculated MW: 37 kDa; Observed MW: 37 kDa

• Storage Conditions:

  Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

• Notes:

  For research use only, not for use in diagnostic procedure.

• Specificity:

  IgG

• Applications Notes:

  Western blot analysis of CDK6 in HeLa lysates using CDK6 antibody.

• Host or Source:

  Rabbit

• CAS Number:

  9007-83-4